TCM
FRLN

Tang Capital Management’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Tang Capital Management’s Portfolio FRLN Stock Details FRLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-100,000
Closed -$258K – 115
2023
Q2 		$258K Buy
+100,000
New +$394K 0.04% 95

Other funds holding FRLN

SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Tang Capital Management's FRLN Position: Q3 2023 in Review

Tang Capital Management sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q3 2023, closing a stake of 100,000 shares — an estimated $258K sold.

Tang Capital Management first reported a position in FRLN in Q2 2023 and held it in 1 quarter. The position peaked at $258K in Q2 2023. 12 funds tracked by Wall St. Rank hold FRLN as of Q3 2023.

  • Tang Capital Management reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q3 2023 after selling out during the quarter.
  • Tang Capital Management sold 100,000 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q3 2023, an estimated $258K.
  • Tang Capital Management first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q2 2023 and held it in 1 quarter.
  • Tang Capital Management's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $258K in Q2 2023.
  • 12 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q3 2023.

Based on Tang Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.